Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes

NCT01393808 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Paricalcitol
OTHER: placebo

Sponsor

Mario Negri Institute for Pharmacological Research

Collaborators

[object Object]